Call us at 778-242-3177 info@medicaladvertising.ca
M.Ad | Medical Advertising
  • Home
  • Packages
    • Organic Package
    • Paid Package
    • Social Package
    • CRM Package
    • AI Package
  • Clients
    • Case Studies
    • Ethics
  • Free Advice
  • Reach Out
Select Page
rTMS in Canada is Catching Up to the Booming US Market

rTMS in Canada is Catching Up to the Booming US Market

by M.Ad | Oct 10, 2019 | Transcranial Magnetic Stimulation

With about 30% of depressed patients not responsive to traditional antidepressants, Transcranial Magnetic Stimulation (TMS) is an approved and largely effective alternative for many Canadians. There are two basic forms of TMS—rTMS and dTMS. The variant of the therapy...
Managing a Negative Online Review for Behavioral Health Professionals

Managing a Negative Online Review for Behavioral Health Professionals

by M.Ad | May 15, 2018 | Online Reputation Management, Transcranial Magnetic Stimulation

Did you know that 80% of internet users search online for health information, and 20% of these searches are about a specific provider? With this level of importance managing your online presence is as important as knowing your financial statements. As a behavioral...
6 Tips for Marketing Transcranial Magnetic Stimulation

6 Tips for Marketing Transcranial Magnetic Stimulation

by M.Ad | Apr 25, 2018 | Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation is a Growing Market The TMS market is expected to continue growing according to a research report published by Orbis Research in early March 2018. In the report they forecast noteworthy market growth up until 2023. The “report...
Careful What You Advertise: Advertising Standards Authority Upholds Complaint Against Neuronix

Careful What You Advertise: Advertising Standards Authority Upholds Complaint Against Neuronix

by M.Ad | Mar 22, 2018 | Transcranial Magnetic Stimulation

Advertising Standards Authority Upholds Complaint Against Neuronix A UK advertiser had a complaint levied against one of their advertising campaigns which promoted NeuroAD as a “medical device for the treatment of Alzheimer’s Disease”. On March 21 2018, after...
Next Entries »

Topics

  • Answer Engine Optimization
  • Artificial Intelligence
  • Automation
  • Blog
  • Case Studies
  • Compliance
  • Concierge Psychiatry
  • Dental
  • fMRI
  • Functional Medicine
  • Generative Engine Optimization
  • Healthcare
  • Interventional Psychiatry
  • Ketamine Treatments
  • Market Analysis
  • Med Spas
  • Media
  • Medical Advertising
  • Medical Devices
  • Medical Insurance
  • Medical Marijuana
  • Medical Practice
  • Medical Sales
  • Medical Tourism and Retreats
  • Medication Management
  • Mental Health
  • NAD+ IV Therapy
  • Neurodegenerative Diseases
  • Online Reputation Management
  • Parkinson's
  • Pharmaceuticals
  • Private Healthcare
  • Referral Marketing
  • Reviews
  • SGB
  • Social Media
  • Substance Use Disorder Treatment Centers
  • Surgery
  • Telemedicine
  • Transcranial Magnetic Stimulation
  • Websites and Landing Pages
  • Weight Loss
  • Weight Management

Other Articles

  • Case Study: Scaling a Single-Location Psychiatry Practice from $1.4 Million to $2.3 Million in Annual Revenue
  • Case Study: How This 2-Clinic Practice in the Southeastern United States Remains Competitive Against a Large-scale Mental Health Services Conglomerate
  • Grow Your Healthcare Business with ChatGPT (AEO and GEO) | Here’s How
  • Case Study: Sold! Midwest Psychiatric Practice Acquired by Texas-Based Private Equity Group
  • 6 Plug and Play AEO and GEO Tips for Medical Practices
[instagram-feed cols=3]
All rights reserved. Copyright 2026. Pintaya Consulting Ltd. Doing Business as MedicalAdvertising.ca.